摘要
川红花是传统的活血化瘀中药材,本文从川红花道地产区简阳的产地生态环境、产区的种植历史、与其它品种质量的比较等多方面研究了川红花的品质特性。结果表明,简阳具有悠久的川红花种植历史,良好的种植技术和品牌效应,产地生态环境因子(大气、土壤、农田灌溉、水质)符合中药材生产质量管理规范(GAP)要求;川红花品种的有效成份黄色素和红色素含量高,其吸收度分别为0.614和0.844,符合《中国药典》2000年版一部要求,并高于其它同生态条件种植的非地道性品种,其水溶性黄酮苷类的含量也高于其它品种;在不影响黄色素和黄酮苷类含量的条件下改进采收加工技术可大幅度提高红色素的含量,吸收度可达1.271,对红色素工业化提取极有利用价值;川红花药材的主要重金属和农药残留量均明显低于国家药材进出口绿色行业标准。实施川红花规范化栽培及按GAP要求建立生产基地后将进一步提高川红花的品质,增强川红花的国际市场竟争能力。
Sichuan safflower(Carthamus tinctorius L.)is a traditional drug for promoting blood circulation and removing blood stasis and its genuine production site is in Jianyang County,Sichuan province,China.This article studies the characteristics of the quality of Sichuan safflower from various aspects,such as its environment,the history of its cultivation and its comparison with other varieties.The study shows that Jianyang has a long cultivation history,high cultivation techniques and good reputation of safflower,that the environmental factors of its production site,such as air,soil and the quality of irrigation water all fit in with the demands of GAP,that its main active components Safftor Yellow and Carthamindin,whose absorption rate is0.614and0.844respectively,are higher than the level provided by China Pharmacopoeia and other non-genuine varieties cultivated in the same conditions,and by the testing method of China Pharmacopoeia,its content of water-soluble flavonoids is also higher than that of others,that Carthamindin could greatly be raised and its absorption rate can reach1.271when the collecting and processing methods are improved without the reduction of the content of safflower yellow and flavonoids and thus it would be greatly benifitial to industrial extraction,and that the residues of main heavy metals and pesticides are obviously lower than the standard of the Green Trade Standards of Importing&Exporting Medicines from Medicinal Plants.It is believed that the quality and international competitiveness of Sichuan Safflower will be further improved when its cultivation and the establishment of its production bases proceed according to standards and GAP.
出处
《世界科学技术-中医药现代化》
2003年第1期62-65,共4页
Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金
四川省科技厅中药现代化科技产业(四川)基地项目
本课题得到雅安三九药业的经费支持。
